During the past decade, CCOP - Kalamazoo conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 22 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Kalamazoo" #1 sponsor was "Radiation Therapy Oncology Group" with 39 trials, followed by "Eastern Cooperative Oncology Group" with 37 trials sponsored, "Children's Oncology Group" with 30 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored and "NSABP Foundation Inc" with 11 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Kalamazoo" #1 collaborator was "National Cancer Institute (NCI)" with 152 trials as a collaborator, "Eastern Cooperative Oncology Group" with 15 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "North Central Cancer Treatment Group" with 6 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Kalamazoo" are "Breast Cancer" (20 trials), "Head and Neck Cancer" (17 trials), "Prostate Cancer" (14 trials), "Leukemia" (13 trials) and "Sarcoma" (11 trials). Many other conditions were trialed in "CCOP - Kalamazoo" in a lesser frequency.

Most popular intervention types in "CCOP - Kalamazoo" are "Drug" (127 trials), "Radiation" (60 trials), "Procedure" (51 trials), "Biological" (41 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (47 trials), "cyclophosphamide" (27 trials), "filgrastim" (22 trials), "cisplatin" (21 trials) and "paclitaxel" (20 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Kalamazoo" are 120 trials for "All" genders, 30 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Kalamazoo". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 151 completed trials in CCOP - Kalamazoo, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Kalamazoo, 12 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 67 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".